openPR Logo
Press release

Allergic Rhino-Conjunctivitis Market Insights: Novel Treatments, Diagnostics & Trends, Future Growth, Industry Insights

10-23-2025 02:18 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Allergic Rhino-Conjunctivitis Market

Allergic Rhino-Conjunctivitis Market

DataM Intelligence has published a new research report on "Allegric Rhino Conjunctivitis Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/allergic-rhino-conjunctivitis-market?kb

Latest M&A Activity

M&A in this market is moderate, focused mainly around expanding allergen immunotherapy portfolios and biologics targeting allergic diseases by pharmaceutical giants and specialized companies such as Immunotek and ALK-Abelló.​

Companies are seeking to consolidate and innovate in newer delivery technologies and improved biologics including monoclonal antibodies, supporting sustained treatment improvement efforts.

Key Players:

Sun Pharmaceutical Industries, Merck & Co., Inc, Novartis AG, Haleon Group, Lofarma S.p.A, ALK-Abello A/S, Stallergenes Greer, HAL Allergy B.V., Hikma Pharmaceuticals PLC, Bausch & Lomb

Recent News and Market Trends

The market is expected to grow significantly over the next decade, driven by rising incidence of allergic rhinitis and conjunctivitis worldwide, along with increased accessibility and awareness of effective treatments.​

Allergen immunotherapy (AIT), including subcutaneous (SCIT) and sublingual (SLIT) routes, continues to be the standard of care with proven long-term efficacy. New biologics and combination therapies are expanding treatment options for resistant or severe cases.​

Emerging biological therapies targeting IgE, IL-5, and other inflammatory pathways are in various clinical stages, promising enhanced precision treatment with fewer side effects.

Growth Forecast Projected:

The Global Allegric Rhino Conjunctivitis Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Allegric Rhino Conjunctivitis Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=allergic-rhino-conjunctivitis-market?kb

Key Segments:

By Drug Type: (Corticosteroids (Nasal and Topical), Decongestants, Antihistamines, Mast Cell Stabilizers, Others)

By Route of Administration: (Oral, Nasal, Topical, Others)

By Age Group: (Pediatric, Adult)

By Distribution Channel: (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies)

New Product Launches (2024-2025)

Immunotek is developing several allergen immunotherapy products including:

MM09: A purified mite allergen extract adsorbed on aluminum hydroxide and polymerized with glutaraldehyde, designed for subcutaneous immunotherapy targeting house dust mite-induced allergic rhinitis and rhino-conjunctivitis. A Phase III trial is planned to assess its efficacy and safety.​

MG56: An immunotherapy targeting grass pollen-induced allergic rhinitis, currently in Phase III clinical development.​

Other candidates like MG01 + T517 are in exploratory stages.

Regeneron Pharmaceuticals is progressing with their monoclonal antibody candidates REGN5713-5714-5715, targeting broader allergic respiratory conditions including allergic rhinitis, with clinical trials ongoing.​

Allergy Therapeutics is also pursuing Grass MATA, a multi-allergen tablet for grass pollen allergies.

Key Biotech Players (Late-Stage Development)

Immunotek - MM09, MG56 (Phase III stage).

Regeneron Pharmaceuticals - REGN5713-5714-5715 (monoclonal antibodies in trials).

Allergy Therapeutics - Grass MATA (allergen immunotherapy tablet).

Blueprint Medicines - Exploring BLU-808 for allergic rhino-conjunctivitis in Canada, with plans to file IND in the US.​

Other active companies include Abdi Ibrahim Pharmaceuticals, Hanmi Pharmaceutical, Emergo Therapeutics, Inimmune, and Revolution Biosciences.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/allergic-rhino-conjunctivitis-market?kb

Latest FDA Approvals

The FDA in 2025 approved Odactra®, the first sublingual tablet for house dust mite allergy, including for pediatric patients aged 5 to 11 years, expanding accessibility and early intervention options.​

Omlyclo® (omalizumab-igec) was approved as the first interchangeable biosimilar to Xolair (omalizumab), relieving moderate to severe allergic asthma and chronic rhinosinusitis with nasal polyps.​

The FDA continues to streamline approvals for digital and AI-enabled devices supporting allergic rhinitis and conjunctivitis diagnosis, monitoring, and therapy optimization.

Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/allergic-rhino-conjunctivitis-market?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Allergic Rhino-Conjunctivitis Market Insights: Novel Treatments, Diagnostics & Trends, Future Growth, Industry Insights here

News-ID: 4236273 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

United States Clinical Microbiology Market 2025: Industry Developments, Future Growth, Share & Industry Insights | bioMérieux SA, Danaher Corporation, Becton, Dickinson and Company
United States Clinical Microbiology Market 2025: Industry Developments, Future G …
Clinical microbiology market size was valued at USD 3.9 billion in 2022 and is estimated to reach USD billion by 2031, growing at a CAGR of 6.5% during the forecast period 2024-2031. DataM Intelligence has published a new research report on "Clinical Microbiology Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers.
United States Immunotherapy Drugs Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Alligator Bioscience, Bristol-Myers Squibb, Novartis AG and AstraZeneca
United States Immunotherapy Drugs Market 2025: Industry Developments, Future Gro …
Immunotherapy Drugs Market Size reached US$ 288.02 Billion in 2024 and is expected to reach US$ 872.64 Billion by 2033, growing at a CAGR of 13.2% during the forecast period 2025-2033. DataM Intelligence has published a new research report on "Immunotherapy Drugs Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The
Classical Swine Fever Vaccines Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Panav Biotech, Boehringer Ingelheim, Ceva, Bioveta, Qilu Animal Health
Classical Swine Fever Vaccines Market 2025: Industry Developments, Future Growth …
Classical Swine Fever Vaccines Market is expected to grow at a CAGR of 7.5% during the forecast period 2024-2031. DataM Intelligence has published a new research report on "Classical Swine Fever Vaccines Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view
United States Adaptogens Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Nutra Industries Inc., Organic India, Amax NutraSource, NutraCap
United States Adaptogens Market 2025: Industry Developments, Future Growth, Shar …
Adaptogens Market is expected to reach at a CAGR of 7% during the forecast period (2024-2031). DataM Intelligence has published a new research report on "Adaptogens Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by

All 5 Releases


More Releases for Rhino

Rhino Play Recent Merger With Schoolscapes UK
RHINO Play SW Ltd has recently acquired UK-wide school playground provider Schoolscapes UK as a part of their growth strategy. With their recent merger with Schoolscapes UK, the playground design and maintenance team of Schoolscapes UK will now be operating under Rhino Play (SW) Ltd. While the company will be operating under the Rhino Play (SW) Ltd umbrella company, Schoolscapes UK, however, will continue to operate as a separate entity.
Latest Case Studies From Rhino Play
PLAYGROUND experts, Rhino Play, have been providing schools and commercial playgrounds with high-quality playground equipment for over 25 years. In the last few months, Rhino Play has worked closely with school playgrounds in and around Devon, Cornwall and Somerset, helping them create high-quality, unique and fun playgrounds for children to enjoy. Rhino Play has created bespoke playgrounds for schools in and around the South West. They work closely with the
luggage rack Market Evaluation with Key Companies (Thule, Yakima, APARCH, Go Rhi …
May 2020, luggage rack Market 2020" report gives distinctive insights worldwide market competition for luggage rack. Focusing on objectives of this report is to categorize dynamics of the market and to supply latest updates like mergers and acquisitions, numerous technological developments, new entrants within the market, that create an impression on totally different segments of the luggage rack market. Apply here for FREE PDF Brochure of this Study: https://inforgrowth.com/sample-request/6338017/luggage-rack-market Top-Manufacturers of luggage
Mahlatini team are joined by Themba the Rhino
Luxury African travel company Mahlatini has launched a new campaign to support Rhino conservation in Africa. The travel retailer which is based in Belfast has teamed up with the Amakhala Game Reserve, in South Africa to help raise awareness of the serious issue of illegal Rhino poaching; which is pushing Black and White Rhinos to the brink of extinction making them an endangered species. Amakhala, a unique conservation initiative that
There’s A Rhino In That Ice! Rhino Marketing Celebrates 3-Year Partnership Wit …
Vancouver, B.C. – Rhino Marketing Inc., one of North America’s leading Internet marketing agencies, has signed a three-year partnership with Canucks Sports & Entertainment (CS&E). The partnership will see the Rhino.ca logo prominently featured at Rogers Arena with a logo in the ice in front of the Canucks bench and will have a strong in-arena and web based presence on Canucks.com. Rhino Marketing will support increased programming on Canucks.com and
Rhino Marketing Inc. Expands Into Los Angeles
Vancouver, B.C. – Rhino Marketing Inc., one of North America’s leading online marketing agencies, has opened a new office in Los Angeles, California, Chief Rhino Doug Morneau recently announced. This expansion will allow Rhino to facilitate business development in the United States and improve service with existing U.S. clients. The new office is conveniently located in the heart of L.A.’s financial district. “We have done significant business in the U.S. market